Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Pomerantz

Showing results (1-10 of 137) with videos related to

Pageof 14
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 18, 2000
Residual HIV-1 replicationR J Pomerantz
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 10, 2001
Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapyR J Pomerantz
Clinics in Laboratory Medicine|September 25, 2002
Clinical HIV-1 virologyR J Pomerantz
American Family Physician|May 29, 1999
HIV patients receiving HAART therapy can still transmit the virus. Highly active antiretroviral chemotherapyR J Pomerantz
Cellular and Molecular Life Sciences : CMLS|November 18, 2003
The HIV-1 Vif protein: a paradigm for viral:cell interactionsR J Pomerantz
JAMA|September 29, 1999
Primary HIV-1 resistance: a new phase in the epidemic?R J Pomerantz
JAMA|November 28, 2001
Initiating antiretroviral therapy during HIV infection: confusion and clarityR J Pomerantz
AIDS (London, England)|June 27, 2001
Residual HIV-1 infection during antiretroviral therapy: the challenge of viral persistenceR J Pomerantz
The New England Journal of Medicine|May 26, 1999
Residual HIV-1 disease in the era of highly active antiretroviral therapyR J Pomerantz
Hospital Practice (1995)|September 29, 1998
How HIV resists eradicationR J Pomerantz
Pageof 14

Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 18, 2000
Residual HIV-1 replicationR J Pomerantz
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 10, 2001
Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapyR J Pomerantz
Clinics in Laboratory Medicine|September 25, 2002
Clinical HIV-1 virologyR J Pomerantz
American Family Physician|May 29, 1999
HIV patients receiving HAART therapy can still transmit the virus. Highly active antiretroviral chemotherapyR J Pomerantz
Cellular and Molecular Life Sciences : CMLS|November 18, 2003
The HIV-1 Vif protein: a paradigm for viral:cell interactionsR J Pomerantz
JAMA|September 29, 1999
Primary HIV-1 resistance: a new phase in the epidemic?R J Pomerantz
JAMA|November 28, 2001
Initiating antiretroviral therapy during HIV infection: confusion and clarityR J Pomerantz
AIDS (London, England)|June 27, 2001
Residual HIV-1 infection during antiretroviral therapy: the challenge of viral persistenceR J Pomerantz
The New England Journal of Medicine|May 26, 1999
Residual HIV-1 disease in the era of highly active antiretroviral therapyR J Pomerantz
Hospital Practice (1995)|September 29, 1998
How HIV resists eradicationR J Pomerantz
Pageof 14